ENOV News and Press, Enovis Corporation

2024-07-02 15:15:06 ET Needham analyst issues BUY recommendation for ENOV on July 2, 2024 01:01PM ET. The previous analyst recommendation was Buy. ENOV was trading at $44.37 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst ...

2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $62.00 for ENOV on 2024-07-02 08:02:00. The adjusted price target was set to $62.00. At the time of the announcement, ENOV was trading at $44.35. The overall price target consensus is at $67.00...

Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Bank of America Healthcare Conference: Ben ...

2024-05-05 17:30:00 ET Summary Enovis, the medtech leftover of Colfax, has seen solid growth, but reports highly adjusted earnings and recently has taken on quite some leverage. The company competes in a wide range of activities in the orthopedic market, facing competition from la...

2024-05-02 14:24:10 ET Enovis Corporation (ENOV) Q1 2024 Earnings Conference Call May 02, 2024, 08:00 AM ET Company Participants Kyle Rose - VP, IR Matthew Trerotola - CEO Phillip Berry - CFO Conference Call Participants Vik Chopra - Wells Fargo J...

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

2024-05-02 06:14:12 ET More on Enovis Corporation Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on Enovis Corporation Historical earnings data for Enovis Corporation Read the full article on Seeking...

Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansion Reported first-quarter net loss from continuing operations of $1.32 per share with adjusted earnings per diluted share of $0.50 Wilmington, DE, May 02, 2024 (GLOBE NEWSWIRE...

Enovis Corporation (ENOV) is expected to report $0.5 for Q1 2024

2024-05-01 11:49:28 ET More on Enovis Corporation Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Don't expect pandemic backlog to fuel orthopedic sales, says Needham Needham sees orthopedics market slowing; favors Enovis, Paragon 28 Seeking Alpha&...